I have read in the past about disappointment that there hasnt been a deal yet for HER Vaxx. I understand there are lots of different cancer types and subsequently lots of different treatments are required to target specific features of these different cancers. IMU has a pipeline of drugs, are they complimentary or are they likely to overlap in the cancers they can treat? Could this be a factor in no one yet offering a good deal for HER Vaxx? I vaguely recall someone making the comment CF33 might be all that is needed for a wide range of solid tumours.
I have read in the past about disappointment that there hasnt...
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 4.8¢ | $1.062M | 21.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 5138497 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 6291273 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |